Videoconference with Mr. Takashi Nagao, new president of Medicago Canada (December 18, 2020)
2020/12/21
On December 18, Consul General Izawa virtually greeted the new president of Medicago Canada, Mr. Takashi Nagao. Medicago is a biopharmaceutical company that develops vaccines and antibody medicine through a technology which uses living plants to produce proteins. Holding 70% of its shares, Japan’s Mitsubishi Tanabe Pharmaceutical Corporation is the majority shareholder.